The FDA is in chaos. But it's not just about the recent leadership shake-up. A new voucher program is causing concern. It seems to be turning drug approvals into a political bargaining chip. The program aims to speed up drug reviews. But the criteria are vague. It's up to the FDA Commissioner to decide who gets the fast track. This has led to some companies getting ...
Novo Nordisk has introduced a new pricing strategy for its weight-loss drugs, Ozempic and Wegovy. Starting now, people without insurance can buy the lowest doses for $199 a month for two months. After that, the price jumps to $349. This deal is available through the drugs' websites and select pharmacies. The lower price only applies to the 0. 25 mg and 0. 5 mg doses...
Jim Gaffigan is set to receive the first Comedy Vanguard Award from Variety and the New York Comedy Festival. This award is given to him for his significant contributions to comedy and his support for fellow comedians. The award ceremony will take place on November 9th at the Upright Citizens Brigade Theater. Gaffigan is known for his unique style and has been in th...
Hollywood's commercial production crews are facing a tough time. Work is drying up, and many are looking elsewhere for opportunities. Diane McArter, who runs Furlined, a company that produces ads for big names like Apple and Eli Lilly, is one of those affected. She's been traveling a lot lately, shooting commercials in places like Glasgow, Prague, Mexico City, and To...
The Trump administration struck a deal with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 drugs. These drugs help with weight loss, diabetes, and other health issues. Starting soon, people will pay about $350 a month for these injectable drugs. This price will drop to $250 over the next two years for those paying without insurance. The deal also includes a d...
Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs for $149 a month. This is a big drop from what they usually charge. ...
Virginia is making a bold move to become a top player in the pharmaceutical world. A new center is being built to train thousands of people every year for jobs in this growing industry. This isn't just any training center. It's a big deal because it brings together community colleges and universities to create programs that can take students from entry-level jobs all...
The first episode of the new series set in Derry starts off feeling like a familiar story. It follows a group of kids who notice that something strange is happening in their town. One boy, Matty, disappears, and his friends start to investigate. At first, it seems like just another tale about a group of outcasts facing a scary clown named Pennywise. The show introdu...
Some actors and actresses who were huge in the 2000s decided to leave Hollywood. They chose different paths, and some even came back. Let's see what they're up to now. Amanda Bynes was last seen in the 2010 movie Easy A. She was great in it, but she left acting to try fashion. She's had some public struggles with her mental health too. Brandan Fraser took a break f...
The market for stomach cancer treatments is growing fast. It was worth $5. 51 billion in 2024 and is expected to reach $12. 64 billion by 2030. This growth is driven by new drugs and therapies. The demand for affordable and painless treatments is also increasing. The aging population is another factor, as older people are more likely to get stomach cancer. Stomach c...